Biotechnology Articles Publish Biotechnology Articles or Industry News

Biotech Professionals and Students - Share your knowledge - Get Recognition
  

Home | Submit Articles | Login   
 
ALL Categories AGRICULTURE CAREERS GENETICS HEALTHCARE ISSUES NEWS STEM CELLS
 
 

Introduction to Pediatric Participation in Clinical Trials - Part I

BY: Preethi Venkateswaran | Category: Biotech Research | Submitted: 2011-06-17 21:42:53
 

   No Photo

•    Post a Comment

Share this article with friends:

           
Share with FACEBOOK ADD TO StumbleUpon ADD TO DEL.ICIO.US ADD TO DIGG

More Social Bookmarks (Twitter etc..)


INTRODUCTION
Medicine and healthcare, for all these years, have been evidence-based in the case of adults, and will continue to be so. However, the quality and efficacy of research in pediatrics are mostly based on anecdotal data and extrapolation of data from adult research. Over 50% of the medications used for children are used as 'off-label' and there have been no records of testing them in children. Over the years doctors have managed to administer estimated doses to children according to their body weight, but this can and has proven to be risky. In 1950, this nightmare came true - Chloramphenicol was used to treat infections in adults resistant to penicillin, but when the same was administered to babies they died, as their immature liver could not break down the drug efficiently. Since then, there has been this long standing debatable question of whether children should participate in clinical trials.

There have been numerous publications relating to the recruitment of adults in trials, but only a handful of them for children. There is a need for understanding that children differ from adults in their individuality, apprehension and biology. The differences between adults and children are based on their physiology, pathology, pharmacodynamics and pharmacokinetics. There are differences in their metabolic pathways, metabolic rates, receptor functions, effector systems and homeostatic movements. Age influences severity of the disease, pathological agents, natural history, dose of medication dependent on body weight and height. One size does not fit all; even among children there are different age groups. Pediatric clinical trials must be carried out with the focus on the novelty of the compound, uniqueness of the conditions in pediatrics, the age ranges of the children, unique safety concerns in pediatrics and the unique requirement of pediatric formulations that serve the needs of the population. Studies must be performed on different age groups such as premature newborns, full-term newborns, infants and toddlers, older children and adolescents

Article Source: http://www.biotecharticles.com/

About Author / Additional Info:
A scientific Writer


Comments on this article: (0 comments so far)

Comment Comment By Comment Date

Leave a Comment   |   Article Views: 957



Additional Articles:
•   Biogas Formation and an Urge For Its Intensive Utilization
•   Are You at Risk For Diabetes?.
•   Nanotechnology - Hopes and Hypes
•   DNA and the Constitution

Latest Articles in "Biotech Research" category:
•   Human Longevity: A Revolution in Biotechnology and Nanotechnology.
•   Nanoparticles as Delivery Device For Gene Therapy
•   Biotechnology as a Tool in Medicine: Focus on Artemisinin
•   Tissue Cells and Skin Cells Reprogrammed Into Embryonic Stem Cells:-
•   Polymerase Chain Reaction (or PCR) - Technique For Amplifying DNA
•   Treatment of Heart Disease With Stem Cells
•   Biological Activities and Bioassays
•   DNA Sequencing: Maxam Gilbert Method
•   PCR Aspects and its Future | PCR versus Cloning
•   Plasmid as Vectors For Plant Transformation
•   Gene Isolation and Characterisation
•   Apoptosis and Cancer: A Review
•   Extraction of Nucleic Acids (DNA and RNA) From Plant Tissues
•   Stem Cells From Bone Marrow and Vein Leftovers Can Heal Damaged Hearts
•   Gene Transfer Techniques: Biolistics, Bacterial and Viral Transformation
•   Breast Cancer: Cactus For Womens Life
•   Mtt Assay: Assess The Viability Of Cell In Culture
•   Medicinal Plants: Source Of Medicine
•   Biotechnology Impact on Alzheimer's Disease


Important Disclaimer: All articles on this website are for general information only and is not a professional or experts advice. We do not own any responsibility for correctness or authenticity of the information presented in this article, or any loss or injury resulting from it. We do not endorse these articles, we are neither affiliated with the authors of these articles nor responsible for their content. Please see our disclaimer section for complete terms.
Page copy protected against web site content infringement by Copyscape
Copyright © 2010 biotecharticles.com - Do not copy articles from this website.
| Home | Disclaimer | Xhtml |